ICOA
CASC

Investment Centers of America’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Investment Centers of America’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,066
Closed -$20K – 635
2016
Q3 		$20K Hold
2,066
– – ﹤0.01% 540
2016
Q2 		$12K Hold
2,066
– – ﹤0.01% 505
2016
Q1 		$16K Hold
2,066
– – ﹤0.01% 527
2015
Q4 		$28K Hold
2,066
– – ﹤0.01% 478
2015
Q3 		$34K Buy
+2,066
New +$42.4K 0.01% 449

Other funds holding CASC

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SH
Sandia Holdings Greenwich, Connecticut $213M AUM 29.35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return

Investment Centers of America's CASC Position: Q4 2016 in Review

Investment Centers of America sold out of Cascadian Therapeutics, Inc. (CASC) in Q4 2016, closing a stake of 2,066 shares — an estimated $20K sold.

Investment Centers of America first reported a position in CASC in Q3 2015 and held it in 5 quarters. The position peaked at $34K in Q3 2015. 57 funds tracked by Wall St. Rank hold CASC as of Q4 2016.

  • Investment Centers of America reported no remaining Cascadian Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • Investment Centers of America sold 2,066 Cascadian Therapeutics, Inc. shares in Q4 2016, an estimated $20K.
  • Investment Centers of America first reported a position in Cascadian Therapeutics, Inc. in Q3 2015 and held it in 5 quarters.
  • Investment Centers of America's Cascadian Therapeutics, Inc. position peaked at $34K in Q3 2015.
  • 57 funds tracked by Wall St. Rank held Cascadian Therapeutics, Inc. as of Q4 2016.

Based on Investment Centers of America's 13F filing for Q4 2016, filed 13 Feb 2017.